Synlett 2011(11): 1543-1546  
DOI: 10.1055/s-0030-1260768
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of a Novel Octahydro Pyrrolo[3,4-c]pyrrole Cyclic Amidine via 1,3-Dipolar Cycloaddition of Azomethine Ylides

Michael Paradowski*, Charlotte A. L. Lane, Torren Peakman
Pfizer Global Research & Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
Fax: +44(1)304649193; e-Mail: Michael.paradowski@pfizer.com;
Further Information

Publication History

Received 15 February 2011
Publication Date:
01 June 2011 (online)

Abstract

A concise synthesis of fused bicyclic pyrrolidines via 1,3-dipolar cycloaddition of azomethine ylides is reported. The exo cycloadduct isomer enables the synthesis of a novel cyclic amidine toward the preparation of a potential human histamine H4 receptor antagonist. The minor endo isomer led to the isolation of a new triazine ring through an intramolecular reductive cyclisation.

    References and Notes

  • 1a Padwa A. Pearson WH. Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry Toward Heterocycles and Natural Products   John Wiley and Sons; New York: 2002.  p.169 
  • 1b Grigg R. Sridharan V. In Advances in Cycloaddition   Vol. 3:  Curran DP. JAI Press; Greenwich / CT: 1993.  p.161 
  • 1c Padwa A. In Comprehensive Organic Synthesis   Vol. 4:  Trost BM. Flemig I. Pergamon Press; Oxford: UK, 1991.  p.1111 
  • 1d Coldham I. Hufton R. Chem. Rev.  2005,  2765 
  • 1e Gothelf KV. In Cycloaddition Reactions in Organic Synthesis   Kobayashi S. Jørgensen KA. Wiley-VCH; Weinheim: 2002. 
  • 2a Harwood LM. Vickers RJ. In Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry Toward Hetero-cycles and Natural Products   John Wiley and Sons; New York: 2002.  Chap. 3. p.169 
  • 2b Dondas AH. Fishwick CWG. Grigg R. Kilner C. Tetrahedron  2004,  3473 
  • 2c Hanessian S. Yun H. Hou Y. Tintelnot-Blomley M. J. Org. Chem.  2005,  6746 
  • 3a Tsuge O. Kanemasa S. Adv. Heterocycl. Chem.  1989,  231 
  • 3b Vedejs E. Advances in Cycloaddition   Vol. 1:  Curran DP. JAI Press; Greenwich: 1988.  p.33 
  • 4 Karzani Y. Surpateanu G. Heterocycles  1999,  863 
  • 5a Garner P. Dogan . J. Org. Chem.  1994,  4 
  • 5b Toyota M. Nishikawa Y. Fukumoto K. Heterocycles  1994,  39 
  • 6a Tsuge O. Kanemasa S. Ohe M. Takenaka S. Chem. Lett.  1986,  973 
  • 6b Grigg R. Idle J. McMeekin P. Surendrakumar S. Vipond D. J. Chem. Soc., Perkin Trans. 1  1988,  2703. 
  • 8 Pellegrino S. Clerici F. Contini A. Leone S. Pilati T. Gelmi ML. Tetrahedron  2009,  1995 
  • 12a Porter MJ. Nandra GS. Elliott JM. Synthesis  2005,  475 
  • 12b Thorsett ED. Harris EE. Patchett AA. J. Org. Chem.  1978,  4276 
7

Mowbray, C. The Discovery and Evaluation of PF-3893787: A Novel Histamine H4 Receptor Antagonist, Gordon Research Conference, Medicinal Chemistry Symposium, 12th August 2010.

9

Synthesis of Amino Cycloadducts 11 and 12 A mixture of N-benzyl glycine (10.2 g, 61.6 mmol), N-Boc-amino acetaldehyde (9.80 g, 61.6 mmol), and N-methyl maleimide (3.42 g, 30.8 mmol) was heated to reflux in toluene (300 mL) for 6 h or until the evolution of CO2 had ceased. The reaction mixture was diluted with H2O (150 mL) and extracted with EtOAc (2 × 150 mL). The combined organic layers were washed successively with sat. NaHCO3 (150 mL) and brine (150 mL), dried over Na2SO4, and concentrated under reduced pressure. The isomers obtained were separated by column chromatography (heptane-EtOAc = 9:1 to 2:3) to give exo adduct 9 (5.24g, 46%) and endo adduct 10 (2.72g, 24%) as white solids. TFA (5 equiv) was added to a solution of each cycloadduct in an ice cold solution of CH2Cl2 (0.3 M), and the reaction mixture was allowed to stir at r.t. for 3 h. After this time, each mixture was concentrated under reduced pressure, neutralised with sat. NaHCO3 and extracted with CH2Cl2. The organic layer was dried over Na2SO4 and concentrated under reduced pressure to give 11 (2.60 g, 68%) and 12 (1.71 g, 86%), respectively.
Compound 11 ( exo): R f  = 0.43 (CH2Cl2-MeOH = 95:5). ¹H NMR (400 MHz, CD3OD): δ = 2.55-2.58 (m, 1 H), 2.77-2.83 (m, 1 H), 2.86-2.90 (m, 2 H), 2.92 (s, 3 H), 3.16-3.21 (m, 1 H), 3.27-3.33 (m, 2 H), 3.44 (d, J = 13.3 Hz, 1 H), 3.85 (d, J = 13.3 Hz, 1 H), 7.23-7.32 (m, 5 H). HRMS: m/z calcd for C15H20N3O2: 274.1555; found: 274.1566 [MH+].
Compound 12 ( endo): R f  = 0.33 (CH2Cl2-MeOH = 95:5). ¹H NMR (400 MHz, CD3OD): δ = 2.58-2.61 (m, 1 H), 2.65 (s, 3 H), 2.98-3.00 (m, 1 H), 3.05-3.10 (m, 1 H), 3.26-3.38 (br m, 3 H), 3.42-3.45 (m, 1 H), 3.55 (d, J = 13.3 Hz, 1 H), 3.90 (d, J = 13.3 Hz, 1 H), 7.22-7.38 (m, 5 H). HRMS: m/z calcd for C15H20N3O2: 274.1555; found: 274.1551 [MH+].

10

Synthesis of Cyclic Amidine 15 To an ice cold solution of Red-Al® (3.5 M in toluene) in THF (50 mL) was added dropwise a solution of exo adduct 11 (2.6g, 9.51mmol) in THF (25 mL). Once added, the reaction mixture was left stirring at r.t. After 3 h, the mixture was cooled with an ice bath and carefully quenched by dropwise addition of 3 N NaOH solution until effervescence had ceased. The mixture was diluted with H2O (50 mL), and the layers were separated. The aqueous layer was extracted with EtOAc (2 × 50 mL). The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (CH2Cl2-MeOH-NH3 = 100:0:0 to 90:10:1) to give exo adduct 13 (1.92 g, 82%) as an amber oil. A solution of exo cycloadduct 13 (725 mg, 2.96 mmol) in EtOH (3 mL) was treated 1-methyl-1,4-cyclohexadiene (4.98 mL, 44.3 mmol) and 20 mol% Pd(OH)2/C (42 mg, 0.29 mmol). The resulting mixture was heated to 80 ˚C for 3 h. After this time, the solution was cooled to r.t. and loaded onto an ion-exchange cartridge (SCX-2), eluting with 2 N NH3 (2 × 5 mL) to give 14 (445 mg, 97%) as a colorless oil. ¹H NMR (400MHz, CD3OD): δ = 2.31 (s, 3 H), 2.30-2.37 (m, 1 H), 2.42-2.67 (m, 6 H), 2.72-2.85 (m, 3 H), 3.11-3.16 (m, 1 H). HRMS: m/z calcd for C8H18N3: 156.1501; found: 156.1498 [MH+].
A suspension of exo cycloadduct 14 (158 mg, 1.02 mmol) and benzimidazole-2-carbonitrile 4 (182 mg, 1.02 mmol) in 2-PrOH (3 mL) was heated at reflux. After 8 h, the reaction mixture was cooled to r.t. and evaporated under reduced pressure. The residue was purified by column chromatog-raphy (CH2Cl2-MeOH-NH3 = 97:3:0.3 to 90:10:1) to give 15 (206 mg, 64%) as a pale yellow solid. ¹H NMR (400 MHz, CDCl3): δ = 2.17 (dd, J = 6.6, 2.7 Hz, 1 H), 2.24 (dd, J = 6.6, 2.7 Hz, 1 H), 2.37 (s, 3 H), 2.49-2.56 (m, 1 H), 2.62-2.68 (m, 1 H), 2.71 (d, J = 9.8 Hz, 1 H), 2.81 (d, J = 9.8 Hz, 1 H), 3.29 (dd, J = 8.2, 4.7 Hz, 1 H), 3.91-3.97 (m, 2 H), 4.10-4.16 (m, 1 H), 5.18 (dd, J = 9.0, 3.9 Hz, 1 H), 7.34-7.39 (m, 2 H). HRMS: m/z calcd for C16H18F2N5: 318.1530; found: 318.1533 [MH+].

11

Synthesis of Triazacyclopenta[ cd ]pentalene 3 To an ice cold solution of Red-Al® (6.6 mL, 23.3 mmol) in THF (5 mL) was added a solution of 12 (637 mg, 2.33 mmol) in THF (5 mL), and the reaction was allowed to stir at r.t. After 16 h, the reaction was quenched with 1 N NaOH (20 mL), diluted with H2O (20 mL) and extracted with EtOAc (20 mL). The organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (CH2Cl2-MeOH-NH3 = 100:0:0 to 90:10:1) to give 3 (200 mg, 35%) as a colorless oil. ¹H NMR(400 MHz, CD3OD): δ = 2.38 (s, 3 H), 2.49-2.51 (m, 1 H), 2.60-2.69 (m, 4 H), 2.78-2.80 (m, 1 H), 2.90-2.93 (m, 1 H), 3.15-3.20 (m, 2 H), 3.48 (d, J = 13.3 Hz, 1 H), 3.82 (d, J = 13.3 Hz, 1 H), 4.13 (d, J = 3.5 Hz, 1 H), 7.22-7.29 (m, 5 H). LRMS: m/z = 244 [MH+].